Literature DB >> 31587249

Venous Thromboembolism despite Ongoing Prophylaxis after Fast-Track Hip and Knee Arthroplasty: A Prospective Multicenter Study of 34,397 Procedures.

Pelle Baggesgaard Petersen1, Christoffer Calov Jørgensen1,2, Henrik Kehlet1,2.   

Abstract

INTRODUCTION: Venous thromboembolism (VTE) is a serious complication to total hip and knee arthroplasty (THA/TKA). However, recent publications found low 90-day incidences of VTE with in-hospital only thromboprophylaxis after fast-track THA and TKA, but with a subgroup with VTE despite thromboprophylaxis.
OBJECTIVES: We aimed to investigate in detail the incidence and risk for VTE despite ongoing thromboprophylaxis after fast-track THA and TKA.
MATERIALS AND METHODS: This is a prospective unselected multicenter cohort from January 2010 to August 2017. Data on preoperative characteristics were entered into the Lundbeck Foundation Centre for Fast-track Hip and Knee Replacement database (www.FTHK.dk). Length of stay (LOS) and complete 90-day follow-up was obtained from the Danish National Patient Registry and review of medical records. Patients with preoperative use of potent anticoagulants were excluded.
RESULTS: Of 34,397 procedures, 32 (0.09%, 22.4% of all VTE) had VTE after median 2 (interquartile range: 2-4) days despite ongoing thromboprophylaxis. Twenty-nine (2.1% of LOS > 5 days) occurred with LOS > 5 days and 3 during primary admission with LOS ≤ 5 days. Note that 78% of VTEs despite ongoing thromboprophylaxis occurred without any identifiable pre-VTE complication. Risk factors were age from 81 to 85 years (odds ratio [OR] 6.3 [95% confidence interval: 1.8-22.4], p = 0.005), body mass index (BMI) < 18.5 (OR 11.1 [1.1-109.2], p = 0.040), BMI 35 to 40 (OR 5.1 [1.0-26.2], p = 0.050), and BMI ≥ 40 (OR 21.8 [4.6-103.6], p < 0.001).
CONCLUSION: VTE after fast-track THA/TKA occurred after median 2 days in 0.09% (22% of all VTE) despite ongoing thromboprophylaxis. Further investigation of this "high-risk" population might help to improve the optimal choice for patient-specific thromboprophylaxis to further reduce incidence of postoperative VTE. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31587249     DOI: 10.1055/s-0039-1696686

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  5 in total

1.  Venous thromboembolism after lower extremity orthopedic surgery: A population-based nationwide cohort study.

Authors:  Inger Lise Gade; Søren Kold; Marianne T Severinsen; Kristian H Kragholm; Christian Torp-Pedersen; Søren R Kristensen; Signe J Riddersholm
Journal:  Res Pract Thromb Haemost       Date:  2020-11-30

2.  Analysis of perioperative risk factors for deep vein thrombosis in patients with femoral and pelvic fractures.

Authors:  Linqin Wu; Bo Cheng
Journal:  J Orthop Surg Res       Date:  2020-12-10       Impact factor: 2.359

3.  Venous thromboembolism in patients hospitalized for knee joint replacement surgery.

Authors:  Karsten Keller; Lukas Hobohm; Stefano Barco; Irene Schmidtmann; Thomas Münzel; Martin Engelhardt; Lukas Eckhard; Stavros V Konstantinides; Philipp Drees
Journal:  Sci Rep       Date:  2020-12-31       Impact factor: 4.379

4.  Preventing VTE following total hip and knee arthroplasty: Is prediction the future?

Authors:  Banne Nemeth; Rob Nelissen; Roopen Arya; Suzanne Cannegieter
Journal:  J Thromb Haemost       Date:  2020-11-10       Impact factor: 5.824

5.  Postoperative 30-day complications after cemented/hybrid versus cementless total hip arthroplasty in osteoarthritis patients > 70 years.

Authors:  Martin Lindberg-Larsen; Pelle Baggesgaard Petersen; Christoffer Calov Jørgensen; Søren Overgaard; Henrik Kehlet
Journal:  Acta Orthop       Date:  2020-04-14       Impact factor: 3.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.